ANI Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:ANIP

Comments

ANI Pharmaceuticals Inc Earnings Estimates

ANIPNASDAQ

Trade with Public

$77.81

-1.09-1.38%

At close: Feb 17, 4:00 PM EST

$77.81

-1.09-1.38%

Pre-Market: 3:00 AM EST

Earnings: Q4 2025 Earnings in 8 days from now on Fri Feb 27th, before the market open

Overview NewsEarningsOptions Guidance Analyst Ratings Insider Trades Short Interest Stock Report

ANI Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:ANIP

ANI Pharmaceuticals (ANIP) is scheduled to report Q4 earnings on February 27, 2026. Analysts estimate EPS of $1.83 and quarterly revenue of $231.81M.

In the most recent quarter (Q3), ANI Pharmaceuticals reported EPS of $2.04, beating estimates of $1.61 by 0.27%. Revenue came in at $227.81M, exceeding the estimate of $212.24M by 0.07%.

ANI Pharmaceuticals has beaten EPS estimates in 8 consecutive quarters.

Over the last 4 quarters, ANI Pharmaceuticals has averaged an EPS surprise of 8.66% and a revenue surprise of 0.09%.

Earnings Date

Feb 27

EPS Estimate

$1.830

Quarterly Revenue Estimate

$231.81M

Annual Revenue
(as of Sep 30)

$826.88M

ANI Pharmaceuticals Earnings History

Analyze the earnings history of ANI Pharmaceuticals using advanced sorting and filters.

ANI Pharmaceuticals (ANIP) Earnings Per Share

The chart below shows ANI Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %
Q3	2025-11-07	$2.04	$1.61	26.7 %
Q2	2025-08-08	$1.80	$1.26	42.9 %
Q1	2025-05-09	$1.70	$-0.06	2933.3 %
Q4	2025-02-28	$1.63	$0.29	462.1 %

ANI Pharmaceuticals (ANIP) Revenue

The chart below shows ANI Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is ANI Pharmaceuticals (NASDAQ:ANIP) reporting earnings?

ANI Pharmaceuticals (ANIP) is scheduled to report earnings on May 8, 2026. The last reported earnings were for reported on November 7, 2025 for Q3.

What were the latest earnings per share (EPS) for ANI Pharmaceuticals (NASDAQ:ANIP)?

The Actual EPS was $2.04, which beat the estimate of $1.61.

What were ANI Pharmaceuticals’s (NASDAQ:ANIP) revenues?

The Actual Revenue was $227.81M, which beat the estimate of $212.24M.

People Also Watch

AtaiBeckley Inc

NASDAQ:ATAI

$3.97

WAVE Life Sciences Ltd

NASDAQ:WVE

$13.30

Phibro Animal Health Corp

NASDAQ:PAHC

$51.08

Rapport Therapeutics Inc

Ocular Therapeutix Inc

ANI Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:ANIP

ANI Pharmaceuticals (ANIP) is scheduled to report Q4 earnings on February 27, 2026. Analysts estimate EPS of $1.83 and quarterly revenue of $231.81M.

In the most recent quarter (Q3), ANI Pharmaceuticals reported EPS of $2.04, beating estimates of $1.61 by 0.27%. Revenue came in at $227.81M, exceeding the estimate of $212.24M by 0.07%.

ANI Pharmaceuticals has beaten EPS estimates in 8 consecutive quarters.

Over the last 4 quarters, ANI Pharmaceuticals has averaged an EPS surprise of 8.66% and a revenue surprise of 0.09%.

Earnings Date

Feb 27

EPS Estimate

$1.830

Quarterly Revenue Estimate

$231.81M

Annual Revenue
(as of Sep 30)

$826.88M